![Scott Myers](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 2 M $ al 31/07/2026
Scott D.
Myers is currently Chairman at Convergent Therapeutics, Inc. and Chairman at Zentalis Pharmaceuticals, Inc., both positions starting in 2024.
Former roles include President & Chief Executive Officer at Aerocrine AB from 2011 to 2015; President, Chief Executive Officer & Director at Cascadian Therapeutics LLC from 2016 to 2018; Chairman & Chief Executive Officer at Rainier Therapeutics, Inc. from 2018 to 2020; President, Chief Executive Officer & Director at AMAG Pharmaceuticals, Inc. in 2020; President, Chief Executive Officer & Director at Viridian Therapeutics, Inc. in 2023; Chairman at Dynavax Technologies Corp.
from 2021 to 2026; Chairman at Sensorion SA from 2021 to 2023; Chairman at Harpoon Therapeutics, Inc. from 2021 to 2024; Chairman at Ironshore Therapeutics, Inc.; Independent Director at Trillium Therapeutics, Inc. in 2021; Independent Director at Orexo AB from 2012 to 2014; Independent Director at Selecta Biosciences, Inc. from 2019 to 2023; Director at Cartesian Therapeutics, Inc. in 2023; Senior Vice President-Marketing at DOV Pharmaceutical, Inc. from 2005 to 2007; and Vice President at UCB SA from 2007 to 2011.
Education includes undergraduate studies at Northwestern University and an MBA from The University of Chicago Booth School of Business.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 16/06/2026 | 395.895 ( 0,42 % ) | 2 M $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ZENTALIS PHARMACEUTICALS, INC. | Presidente | 13/11/2024 |
Convergent Therapeutics, Inc.
 Convergent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops radiopharmaceutical therapies for prostate cancer | Presidente | 01/03/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
| DYNAVAX TECHNOLOGIES CORPORATION | Presidente | 10/02/2026 |
| HARPOON THERAPEUTICS, INC. | Presidente | 11/03/2024 |
| VIRIDIAN THERAPEUTICS, INC. | Director Ejecutivo | 01/11/2023 |
| CARTESIAN THERAPEUTICS, INC. | Director/Miembro de la Junta | 01/10/2023 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 18 |
|---|---|
Dynavax Technologies Corp.
 Dynavax Technologies Corp. BiotechnologyHealth Technology Develops and commercializes novel products to prevent and treat infectious diseases | Health Technology |
DOV Pharmaceutical, Inc.
 DOV Pharmaceutical, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers and develops novel drugs | Commercial Services |
Aerocrine AB
 Aerocrine AB Electronic Equipment/InstrumentsElectronic Technology Manufactures and distributes medical devices for asthma patients | Electronic Technology |
Trillium Therapeutics, Inc.
 Trillium Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches, develops and manufactures medicines & therapies for cancer | Health Technology |
Cascadian Therapeutics LLC
 Cascadian Therapeutics LLC Medical SpecialtiesHealth Technology Develops therapeutic products for the treatment of cancer | Health Technology |
Ironshore Therapeutics, Inc.
 Ironshore Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and distributes central nervous system stimulant prescription medicines | Health Technology |
Selecta Biosciences, Inc.
 Selecta Biosciences, Inc. BiotechnologyHealth Technology Develops targeted immunotherapies and vaccines to treat and prevent diseases | Health Technology |
UCB SA
 UCB SA Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Orexo AB
 Orexo AB Pharmaceuticals: MajorHealth Technology Manufactures and commercializes pharmaceutical products | Health Technology |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Sensorion SA
 Sensorion SA Pharmaceuticals: MajorHealth Technology Operates as a research and development company that discovers drugs to treat inner ear disorders | Health Technology |
The University of Chicago Booth School of Business
 The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rainier Therapeutics, Inc.
 Rainier Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company developing a targeted biologic for the potential treatment of both early stage and metastatic bladder cancer | Health Technology |
Harpoon Therapeutics, Inc.
 Harpoon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immunotherapy company that develops T-cell engagers to treat cancer and other diseases | Health Technology |
Viridian Therapeutics, Inc.
 Viridian Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and manufactures monoclonal antibody products | Health Technology |
Zentalis Pharmaceuticals, Inc.
 Zentalis Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops clinical therapeutics for targeting fundamental cancer pathways | Health Technology |
Convergent Therapeutics, Inc.
Convergent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops radiopharmaceutical therapies for prostate cancer | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
